KR980000450A - Animal disease prevention and treatment using chitosan oligosaccharide derivative - Google Patents

Animal disease prevention and treatment using chitosan oligosaccharide derivative Download PDF

Info

Publication number
KR980000450A
KR980000450A KR1019980001958A KR19980001958A KR980000450A KR 980000450 A KR980000450 A KR 980000450A KR 1019980001958 A KR1019980001958 A KR 1019980001958A KR 19980001958 A KR19980001958 A KR 19980001958A KR 980000450 A KR980000450 A KR 980000450A
Authority
KR
South Korea
Prior art keywords
livestock
chitosan
chitosan oligosaccharide
agent
treatment
Prior art date
Application number
KR1019980001958A
Other languages
Korean (ko)
Inventor
김희경
강문일
김희선
Original Assignee
김희경
강문일
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김희경, 강문일 filed Critical 김희경
Priority to KR1019980001958A priority Critical patent/KR980000450A/en
Publication of KR980000450A publication Critical patent/KR980000450A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

목적purpose

가축질병 감염 예방제, 가축질병 치료제 및 가축 증체율 증강제를 제공함을 목적을 한다. 구성It is an object of the present invention to provide a livestock disease prevention agent, a livestock disease treatment agent, and a livestock weight increasing agent. Configuration

가축에게 키토산 및 키토산올리고당 유도체를 0.0001-1wt%를 음용수에 혼합하여 경구 투여하므로서 대장균속등, 리스테리아속, 포도상구균, 연쇄상구균, 살모넬라속, 크렙지엘라속등의 세균과 아스퍼질러스속 등의 곰팡이에 대한감염예방, 치료 및 증체율 증강 효과가 있다.Bacteria such as Escherichia coli, Listeria, Staphylococcus, Streptococcus, Salmonella, Krebziella, etc., and fungi such as Aspergillus, are mixed with oral doses of chitosan and chitosan oligosaccharide derivatives in drinking water. It has the effect of preventing, treating, and increasing the body weight gain.

Description

키토산 올리고당 유도체를 이용한 가축질병 예방 및 치료제Animal disease prevention and treatment using chitosan oligosaccharide derivative

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (15)

키토산 및 키토산올리고당 제제를 주유효성분으로 하는 가축질병 감염 예방제.Livestock disease prevention agent which has chitosan and chitosan oligosaccharide preparation as an active ingredient. 키토산 및 키토산올리고당 제제를 주유효성분으로 하는 가축질병 치료제.A livestock disease treatment agent comprising chitosan and chitosan oligosaccharide preparations as active ingredients. 키토산 및 키토산올리고당 제제를 주유효성분으로 하는 가축 증체율 증강제.Livestock growth rate enhancer comprising chitosan and chitosan oligosaccharide preparations as active ingredients. 제1항에 있어서, 키토산올리고당의 당체가 1개~16개로 구성된 분자량을 함유하고 있음을 특징으로 하는 가축질병 감염예방제.The livestock disease prevention agent according to claim 1, wherein the sugar of chitosan oligosaccharide contains a molecular weight of 1 to 16. 제2에 있어서, 키토산올리고당의 당체가 1개~16개로 구성된 분자량을 함유하고 있음을 특징으로 하는 가축 질병 치료제.The livestock disease therapeutic agent according to claim 2, wherein the sugar of chitosan oligosaccharide contains a molecular weight composed of 1 to 16. 제3에 있어서, 키토산올리고당의 당체가 1개~16개로 구성된 분자량을 함유하고 있음을 특징으로 하는 가축 증체율 증강제.The livestock gain increasing agent according to claim 3, wherein the sugar of chitosan oligosaccharide contains a molecular weight composed of 1 to 16. 제1항~제6항에 있어서, 키토산 및 키토산올리고당의 탈아세틸화도가 60% 이상의 물성을 사용함을 특징으로 하는 제제.The preparation according to claim 1, wherein the degree of deacetylation of chitosan and chitosan oligosaccharides is at least 60%. 제1항에 있어서, 키토산올리고당을 0.0001wt%~1wt%를 음용수에 혼합하여 경구투여를 특징으로 하는 가축질병 치료제.The method of claim 1, wherein chitosan oligosaccharides 0.0001wt% ~ 1wt% mixed animal drinking water characterized in that oral administration. 제2에 있어서, 키토산올리고당을 0.0001wt%~1wt%를 음용수에 혼합하여 경구투여를 특징으로 하는 가축질병 치료제.[Claim 2] The livestock disease therapeutic agent according to claim 2, wherein chitosan oligosaccharides are mixed orally with 0.0001wt% to 1wt% of drinking water. 제3항에 있어서, 키토산올리고당을 0.0001wt%~1wt%를 음용수에 혼합하여 경구투여를 특징으로 하는 가축 증체율 증강제.The livestock growth rate enhancer according to claim 3, wherein chitosan oligosaccharide is mixed orally with 0.0001wt% to 1wt% of drinking water. 제1항 또는 제4항에 있어서, 대장균속등, 리스테리아속, 포도상구균, 연쇄상구균, 살모넬라속, 크렙지엘라속등의 세균과 아스퍼질러스속 등의 곰팡이중 일반항생제에 내성 보유 및 내성 미보유 병원미생물에 대하여 감염 예방함을 특징으로 하는 가축질병 감염예방제.The method according to claim 1 or 4, wherein the bacterium possesses resistance and resistance to common antibiotics among bacteria such as Escherichia coli, Listeria, Staphylococcus, Streptococcus, Salmonella, and Crepgiella, and fungi such as Aspergillus. Livestock disease infection prevention agent, characterized by preventing infection against microorganisms. 제2항 또는 제5항에 있어서, 대장균속등, 리스테리아속, 포도상구균, 연쇄상구균, 살모넬라속, 크렙지엘라속등의 세균과 아스퍼질러스속 등의 곰팡이중 일반항생제에 내성 보유 및 내성 미보유 병원미생물에 대하여 치료함을 특징으로 하는 가축질병 치료제.The method according to claim 2 or 5, wherein the bacterium possesses resistance and resistance to general antibiotics among bacteria such as Escherichia coli, Listeria, Staphylococcus, Streptococcus, Salmonella, and Crepgiella, and fungi such as Aspergillus. Animal disease treatment, characterized in that the treatment for microorganisms. 제1항 또는 제4항에 있어서, 가축으로서는 돼지, 소, 닭, 오리등임을 특징으로 하는 가축질병 감염 예방제.The livestock disease prevention agent according to claim 1 or 4, wherein the livestock is pig, cow, chicken, duck, or the like. 제2항 또는 제5항에 있어서, 가축으로서는 돼지, 소, 닭, 오리등임을 특징으로 하는 가축질병 감염 치료제.The agent for treating livestock diseases according to claim 2 or 5, wherein the livestock is pig, cow, chicken, duck, or the like. 제3항 또는 제7항에 있어서, 가축으로서는 돼지, 소, 닭, 오리등임을 특징으로 하는 가축 증체율 증강제.The livestock growth rate enhancer according to claim 3 or 7, wherein the livestock is pig, cow, chicken, duck, or the like. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019980001958A 1998-01-23 1998-01-23 Animal disease prevention and treatment using chitosan oligosaccharide derivative KR980000450A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980001958A KR980000450A (en) 1998-01-23 1998-01-23 Animal disease prevention and treatment using chitosan oligosaccharide derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980001958A KR980000450A (en) 1998-01-23 1998-01-23 Animal disease prevention and treatment using chitosan oligosaccharide derivative

Publications (1)

Publication Number Publication Date
KR980000450A true KR980000450A (en) 1998-03-30

Family

ID=65892779

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980001958A KR980000450A (en) 1998-01-23 1998-01-23 Animal disease prevention and treatment using chitosan oligosaccharide derivative

Country Status (1)

Country Link
KR (1) KR980000450A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000050331A (en) * 1999-01-06 2000-08-05 김희경 A Veterinary Preparation for Preaenting and Treating Diseases of Livestock With Mineral Salt Chitosan Oligosaccharide Derivatives as an Effective Component
KR100371092B1 (en) * 1999-12-09 2003-02-05 주식회사대성미생물연구소 The composition of antibacterial complex for animal
KR100412253B1 (en) * 2001-12-01 2003-12-31 이지생명과학(주) Chitosan Aqueous Solution for Animal Drugs Enhancing Antipathy and Physiological Activity and Method of Manufacturing the Same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000050331A (en) * 1999-01-06 2000-08-05 김희경 A Veterinary Preparation for Preaenting and Treating Diseases of Livestock With Mineral Salt Chitosan Oligosaccharide Derivatives as an Effective Component
KR100371092B1 (en) * 1999-12-09 2003-02-05 주식회사대성미생물연구소 The composition of antibacterial complex for animal
KR100412253B1 (en) * 2001-12-01 2003-12-31 이지생명과학(주) Chitosan Aqueous Solution for Animal Drugs Enhancing Antipathy and Physiological Activity and Method of Manufacturing the Same

Similar Documents

Publication Publication Date Title
AU657615B2 (en) Chlorine dioxide containing composition for prevention and treatment of bacterial infections
CA2225713A1 (en) Pharmaceutical compositions containing herbal-based active ingredients; method for preparing same and uses of same for medical and veterinary purposes
US20090275657A1 (en) Fatty acid antimicrobial
US6306835B1 (en) Biocidal chitosan derivatives
BR9507099A (en) Dosage form sterilization method sterilizing composition and animal food supplement comprising acidified nitrite as an anti-microbial agent
KR100474945B1 (en) Composition for reducing somatic cell and preventing or treating mastitis of dairy cattle
AU721692B2 (en) Teat dipping agent
US11980185B2 (en) Bioflavonoid compositions and their use for water purification and food preservation
CN104399017A (en) Composition for prevention and treatment of female vulva inflammation
KR980000450A (en) Animal disease prevention and treatment using chitosan oligosaccharide derivative
JPH0656675A (en) Livestock mammary inflammation-preventing agent
NL1037411C2 (en) COMPOSITION COMPRISING ANISIC ACID, A DERIVATIVE THEREOF AND / OR A PHARMACEUTICAL ACCEPTABLE SALT, AND AN ACID BUFFER, ALSO A DOSING FORM AND APPLICATIONS THEREOF.
CN106880832A (en) The new application of glutathione
JPH0656689A (en) Preventing and treating composition for infectious diarrhea
AU2021234626A1 (en) Compositions for disrupting biofilm formation and for treating biofilm-related disorders
KR102051612B1 (en) Composition for sterilization using synergistic antimicrobial effect of thiamine dilaurylsulfate and medium chain fatty acid
CN110538089A (en) Antibacterial halitosis-removing pet toothpaste
KR100299669B1 (en) Solution for sterilization of nipple and prevention of mastitis in dairy cows
Micinski et al. Hazards to humans and animals associated with antibiotic misuse
RU2136173C1 (en) Feed additive
JPH06145066A (en) Medical composition for enhancement of effect of chemotherapeutic agent and for prevention and improvement of infectious disease
Gordin et al. Amdinocillin therapy of experimental animal infections
RU2080113C1 (en) Method of increase of safety and productivity of agriculture animals
KR100295742B1 (en) Complex antibiotic composition for animal bacterial infections
US20050202052A1 (en) Flavored medicaments to deter or attract and kill microorganisms

Legal Events

Date Code Title Description
A201 Request for examination
G15R Request for early opening
N231 Notification of change of applicant
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E601 Decision to refuse application